[{"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-001", "question": "A 68-year-old man with a history of severe aortic stenosis (mean gradient 48 mmHg, AVA 0.7 cm²) presents with decompensated heart failure. He is hypotensive (85/50 mmHg) and hypoxic despite high-flow oxygen. Transthoracic echocardiography shows a hyperdynamic left ventricle with near-cavity obliteration, severe mitral regurgitation (new, eccentric posteriorly directed jet), and systolic anterior motion of the mitral valve with LVOT obstruction (peak gradient 120 mmHg). Which of the following is the single most appropriate immediate pharmacologic intervention?", "options": ["Intravenous phenylephrine infusion", "Intravenous esmolol infusion", "Intravenous nitroglycerin infusion", "Intravenous furosemide bolus", "Intravenous milrinone infusion"], "answer": "A", "answer_index": 0, "explanation": "This patient has severe aortic stenosis with a dynamic LVOT obstruction (systolic anterior motion) precipitated by hypovolemia and hypercontractility, leading to hypotension and secondary mitral regurgitation. Phenylephrine, an alpha-agonist, increases afterload and blood pressure, which reduces the LVOT gradient and improves forward flow. Esmolol (negative inotrope) could worsen heart failure in the setting of severe AS. Nitroglycerin and furosemide reduce preload, exacerbating the obstruction. Milrinone is a positive inotrope and vasodilator, which would dramatically worsen the LVOT gradient and hypotension.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best answer. The vignette describes a complex scenario: severe aortic stenosis with superimposed dynamic LVOT obstruction (SAM, gradient 120 mmHg), hyperdynamic LV with near-cavity obliteration, new eccentric MR, and hypotension. Key discriminating findings are hypotension (85/50), hyperdynamic LV with cavity obliteration, SAM with high LVOT gradient, and severe AS background. The clinical problem is managing hypotension in combined severe AS plus dynamic LVOT obstruction (hypertrophic obstructive physiology). Phenylephrine (A) increases SVR/afterload, raising BP and reducing LVOT gradient by decreasing LV hypercontractility's effect—this addresses both the hypotension and the dynamic obstruction. Esmolol (B) risks worsening cardiac output in severe AS despite negative inotropy benefits. Nitroglycerin (C) and furosemide (D) reduce preload, worsening cavity obliteration and LVOT obstruction. Milrinone (E) combines positive inotropy and vasodilation, catastrophically worsening both LVOT gradient and hypotension. The keyed answer is medically sound and uniquely defensible. Medical accuracy: The management aligns with standard approach to dynamic LVOT obstruction (increase afterload, avoid preload reduction, avoid positive inotropes). No contradictions exist. Minimal fix: None needed; item is valid and accurate.\", \"medical_accuracy_score\": \"5\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The vignette describes a complex scenario: severe aortic stenosis with superimposed dynamic LVOT obstruction (SAM, gradient 120 mmHg), hyperdynamic LV with near-cavity obliteration, new eccentric MR, and hypotension. Key discriminating findings are hypotension (85/50), hyperdynamic LV with cavity obliteration, SAM with high LVOT gradient, and severe AS background. The clinical problem is managing hypotension in combined severe AS plus dynamic LVOT obstruction (hypertrophic obstructive physiology). Phenylephrine (A) increases SVR/afterload, raising BP and reducing LVOT gradient by decreasing LV hypercontractility's effect—this addresses both the hypotension and the dynamic obstruction. Esmolol (B) risks worsening cardiac output in severe AS despite negative inotropy benefits. Nitroglycerin (C) and furosemide (D) reduce preload, worsening cavity obliteration and LVOT obstruction. Milrinone (E) combines positive inotropy and vasodilation, catastrophically worsening both LVOT gradient and hypotension. The keyed answer is medically sound and uniquely defensible. Medical accuracy: The management aligns with standard approach to dynamic LVOT obstruction (increase afterload, avoid preload reduction, avoid positive inotropes). No contradictions exist. Minimal fix: None needed; item is valid and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-002", "question": "A 3-day-old full-term neonate, born via uncomplicated vaginal delivery, is noted to have progressive tachypnea, grunting, and hypoxemia requiring 60% FiO2. Chest X-ray shows diffuse granular opacities with air bronchograms. Surfactant administration provides minimal improvement. Echocardiogram shows normal cardiac anatomy, but there is severe pulmonary hypertension with suprasystemic right ventricular pressures and right-to-left shunting across a patent foramen ovale. Which of the following underlying conditions is the most likely cause of this refractory pulmonary hypertension of the newborn?", "options": ["Congenital alveolar capillary dysplasia", "Meconium aspiration syndrome", "Transient tachypnea of the newborn", "Group B streptococcal pneumonia", "Idiopathic respiratory distress syndrome"], "answer": "A", "answer_index": 0, "explanation": "Congenital alveolar capillary dysplasia (ACD) with misalignment of pulmonary veins is a rare, lethal lung developmental disorder that presents identically to severe persistent pulmonary hypertension of the newborn (PPHN) but is completely refractory to all standard therapies, including surfactant, inhaled nitric oxide, and ECMO. The history of a full-term infant with rapid progression and lack of response to surfactant is classic. Meconium aspiration and sepsis can cause severe PPHN but typically show some response to aggressive management. Transient tachypnea and idiopathic RDS are not associated with such severe, immediate refractory pulmonary hypertension.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: U (Underspecified) leading to M (Multiple answers defensible). Verdict: Not uniquely determinable. The stem describes a 3-day-old term neonate with severe respiratory distress, diffuse granular opacities, and refractory pulmonary hypertension unresponsive to surfactant. Key discriminating findings: full-term birth, progressive symptoms, minimal surfactant response, severe PPHN with suprasystemic RV pressures. The question asks for the \\\"most likely cause\\\" but lacks critical information to distinguish between several plausible diagnoses. While alveolar capillary dysplasia (ACD) is classically refractory to all therapies, the stem does not specify that inhaled nitric oxide or other PPHN-specific treatments were attempted and failed—only that surfactant provided \\\"minimal improvement.\\\" Group B streptococcal pneumonia (option D) can present identically in a 3-day-old with severe PPHN, granular opacities, and poor surfactant response, especially early-onset sepsis. Meconium aspiration (option B) is also plausible despite no meconium history being mentioned (underspecified). The item assumes ACD based on refractory nature, but without documenting failure of iNO/ECMO or excluding infection, multiple answers remain defensible. Medical accuracy: The teaching point about ACD is correct but the clinical scenario is insufficiently detailed. Minimal fix: Add \\\"Blood cultures negative, no response to inhaled nitric oxide\\\" to uniquely support ACD.\", \"medical_accuracy_score\": \"4\", \"logical_validity\": false, \"logical_false_reason\": \"U\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: U (Underspecified) leading to M (Multiple answers defensible). Verdict: Not uniquely determinable. The stem describes a 3-day-old term neonate with severe respiratory distress, diffuse granular opacities, and refractory pulmonary hypertension unresponsive to surfactant. Key discriminating findings: full-term birth, progressive symptoms, minimal surfactant response, severe PPHN with suprasystemic RV pressures. The question asks for the \"most likely cause\" but lacks critical information to distinguish between several plausible diagnoses. While alveolar capillary dysplasia (ACD) is classically refractory to all therapies, the stem does not specify that inhaled nitric oxide or other PPHN-specific treatments were attempted and failed—only that surfactant provided \"minimal improvement.\" Group B streptococcal pneumonia (option D) can present identically in a 3-day-old with severe PPHN, granular opacities, and poor surfactant response, especially early-onset sepsis. Meconium aspiration (option B) is also plausible despite no meconium history being mentioned (underspecified). The item assumes ACD based on refractory nature, but without documenting failure of iNO/ECMO or excluding infection, multiple answers remain defensible. Medical accuracy: The teaching point about ACD is correct but the clinical scenario is insufficiently detailed. Minimal fix: Add \"Blood cultures negative, no response to inhaled nitric oxide\" to uniquely support ACD.", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "U", "verdict": "FAIL", "fail_reason": "U"}, "judge_verdict": "FAIL", "judge_fail_reason": "U", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-003", "question": "A 42-year-old woman is brought to the ED after a high-speed motor vehicle collision. Primary survey reveals a Glasgow Coma Scale of 14, heart rate 130 bpm, BP 88/50 mmHg, and SpO2 94% on room air. Focused Assessment with Sonography for Trauma (FAST) is positive for fluid in the hepatorenal recess. After initiating a massive transfusion protocol, her blood pressure transiently improves with crystalloid, then drops again. Bedside ultrasound now shows a new, large pericardial effusion with diastolic right ventricular collapse. Which of the following is the most appropriate immediate procedural intervention?", "options": ["Emergency department thoracotomy", "Pericardiocentesis via subxiphoid approach", "Left anterolateral tube thoracostomy", "Right tube thoracostomy", "Laparotomy with aortic cross-clamping"], "answer": "B", "answer_index": 1, "explanation": "The patient has developed cardiac tamponade (evidenced by diastolic RV collapse on ultrasound) in the context of trauma and a positive FAST exam, suggesting concurrent intra-abdominal hemorrhage. In blunt trauma, the cause is likely myocardial rupture or coronary vessel injury. Pericardiocentesis is the immediate life-saving procedure to relieve tamponade while simultaneously preparing for definitive operative management. ED thoracotomy is indicated for penetrating trauma with recent loss of signs of life. Tube thoracostomy addresses hemothorax, not pericardial tamponade. Laparotomy addresses the abdominal hemorrhage but would not relieve the cardiac tamponade, and the patient would likely arrest on induction of anesthesia.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: M (Multiple answers defensible). Verdict: Not uniquely determinable. The stem describes a trauma patient with both cardiac tamponade (pericardial effusion with diastolic RV collapse) and intra-abdominal hemorrhage (positive FAST in hepatorenal recess). Key discriminating findings: high-speed MVC (blunt trauma), hemodynamic instability despite transfusion, positive FAST, and new tamponade physiology. The clinical problem asks for the \\\"most appropriate immediate\\\" intervention when two life-threatening injuries coexist. Option B (pericardiocentesis) addresses tamponade but leaves abdominal hemorrhage untreated. Option E (laparotomy) addresses the abdominal source but risks arrest from tamponade during induction, as the rationale notes. However, Option A (ED thoracotomy) is also defensible: in trauma with cardiac tamponade plus hemorrhagic shock, ED thoracotomy allows simultaneous pericardial decompression, direct cardiac repair if needed, and aortic cross-clamping to redirect blood flow—addressing both injuries. The rationale dismisses thoracotomy as \\\"for penetrating trauma with recent loss of signs,\\\" but blunt cardiac rupture with tamponade and refractory shock is an accepted indication (EAST guidelines). Medical accuracy: The pathophysiology is sound, but the item conflates procedural priorities without clearly establishing which injury is immediately lethal. Minimal fix: Specify penetrating mechanism or state \\\"patient maintains pulse\\\" to exclude thoracotomy, making pericardiocentesis unambiguous.\", \"medical_accuracy_score\": \"3\", \"logical_validity\": false, \"logical_false_reason\": \"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: M (Multiple answers defensible). Verdict: Not uniquely determinable. The stem describes a trauma patient with both cardiac tamponade (pericardial effusion with diastolic RV collapse) and intra-abdominal hemorrhage (positive FAST in hepatorenal recess). Key discriminating findings: high-speed MVC (blunt trauma), hemodynamic instability despite transfusion, positive FAST, and new tamponade physiology. The clinical problem asks for the \"most appropriate immediate\" intervention when two life-threatening injuries coexist. Option B (pericardiocentesis) addresses tamponade but leaves abdominal hemorrhage untreated. Option E (laparotomy) addresses the abdominal source but risks arrest from tamponade during induction, as the rationale notes. However, Option A (ED thoracotomy) is also defensible: in trauma with cardiac tamponade plus hemorrhagic shock, ED thoracotomy allows simultaneous pericardial decompression, direct cardiac repair if needed, and aortic cross-clamping to redirect blood flow—addressing both injuries. The rationale dismisses thoracotomy as \"for penetrating trauma with recent loss of signs,\" but blunt cardiac rupture with tamponade and refractory shock is an accepted indication (EAST guidelines). Medical accuracy: The pathophysiology is sound, but the item conflates procedural priorities without clearly establishing which injury is immediately lethal. Minimal fix: Specify penetrating mechanism or state \"patient maintains pulse\" to exclude thoracotomy, making pericardiocentesis unambiguous.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-004", "question": "A 28-year-old woman presents with a 6-month history of symmetric inflammatory polyarthritis affecting her wrists, MCPs, and knees, morning stiffness >1 hour, and a new facial rash. Labs show ANA 1:1280 (speckled), anti-dsDNA negative, anti-Smith positive, anti-RNP positive, complement levels normal, and urinalysis with 2+ protein but no cellular casts. She is started on hydroxychloroquine. Two weeks later, she develops acute dyspnea, pleuritic chest pain, and hypoxia. CT pulmonary angiography shows no pulmonary embolism but reveals extensive bilateral ground-glass opacities and pleural effusions. Which of the following is the most likely diagnosis?", "options": ["Lupus pneumonitis", "Drug reaction to hydroxychloroquine", "Acute pulmonary hemorrhage from vasculitis", "Pulmonary hypertension due to SLE", "Opportunistic infection due to immunosuppression"], "answer": "A", "answer_index": 0, "explanation": "The patient has SLE (meeting criteria with arthritis, malar rash, anti-Smith positivity). The acute respiratory presentation with ground-glass opacities and pleural effusions in this context is most consistent with acute lupus pneumonitis, a rare but severe manifestation of SLE. Timing makes drug reaction unlikely, as hydroxychloroquine toxicity is typically chronic and not acute pulmonary. Pulmonary hemorrhage would show falling hematocrit and more alveolar filling. Pulmonary hypertension is a chronic process. Opportunistic infection is improbable given the very short course of a minimally immunosuppressive agent (hydroxychloroquine).", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best answer. The stem describes a 28-year-old woman meeting SLE criteria (symmetric polyarthritis, facial rash, ANA 1:1280, anti-Smith positive, anti-RNP positive, proteinuria). Two weeks after starting hydroxychloroquine, she develops acute dyspnea, pleuritic chest pain, hypoxia, bilateral ground-glass opacities, and pleural effusions without PE. Key discriminating findings: (1) established SLE diagnosis, (2) acute pulmonary presentation with ground-glass opacities and pleural effusions, (3) very short hydroxychloroquine exposure (2 weeks). Option A (lupus pneumonitis) is the best answer—acute lupus pneumonitis classically presents with dyspnea, pleuritic pain, ground-glass opacities, and pleural effusions in SLE patients. Option B is implausible; hydroxychloroquine pulmonary toxicity requires months-to-years of exposure and presents with chronic interstitial changes, not acute ground-glass opacities after 2 weeks. Option C (pulmonary hemorrhage) would typically show hemoptysis, falling hematocrit, and diffuse alveolar hemorrhage pattern rather than ground-glass opacities with effusions. Option D (pulmonary hypertension) is a chronic process incompatible with acute 2-week presentation. Option E (opportunistic infection) is unlikely given hydroxychloroquine's minimal immunosuppression and short duration. The item is logically valid with a unique best answer matching the key. Medical accuracy is excellent—consistent with standard SLE manifestations and hydroxychloroquine safety profile. Minimal fix: none needed.\", \"medical_accuracy_score\": \"5\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The stem describes a 28-year-old woman meeting SLE criteria (symmetric polyarthritis, facial rash, ANA 1:1280, anti-Smith positive, anti-RNP positive, proteinuria). Two weeks after starting hydroxychloroquine, she develops acute dyspnea, pleuritic chest pain, hypoxia, bilateral ground-glass opacities, and pleural effusions without PE. Key discriminating findings: (1) established SLE diagnosis, (2) acute pulmonary presentation with ground-glass opacities and pleural effusions, (3) very short hydroxychloroquine exposure (2 weeks). Option A (lupus pneumonitis) is the best answer—acute lupus pneumonitis classically presents with dyspnea, pleuritic pain, ground-glass opacities, and pleural effusions in SLE patients. Option B is implausible; hydroxychloroquine pulmonary toxicity requires months-to-years of exposure and presents with chronic interstitial changes, not acute ground-glass opacities after 2 weeks. Option C (pulmonary hemorrhage) would typically show hemoptysis, falling hematocrit, and diffuse alveolar hemorrhage pattern rather than ground-glass opacities with effusions. Option D (pulmonary hypertension) is a chronic process incompatible with acute 2-week presentation. Option E (opportunistic infection) is unlikely given hydroxychloroquine's minimal immunosuppression and short duration. The item is logically valid with a unique best answer matching the key. Medical accuracy is excellent—consistent with standard SLE manifestations and hydroxychloroquine safety profile. Minimal fix: none needed.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-005", "question": "A 55-year-old man with a history of MEN1 syndrome (previous parathyroidectomy, pancreatic neuroendocrine tumor resection) presents with profound hypoglycemia (glucose 38 mg/dL) and inappropriately elevated serum insulin and C-peptide during a supervised fast. Localizing studies, including endoscopic ultrasound and Ga-68 DOTATATE PET/CT, show no identifiable pancreatic lesion. Which of the following is the most appropriate next step in management?", "options": ["Empiric distal pancreatectomy", "Initiation of diazoxide therapy", "Selective arterial calcium stimulation with hepatic venous sampling", "Empiric total pancreatectomy", "Long-acting somatostatin analog therapy (e.g., lanreotide)"], "answer": "C", "answer_index": 2, "explanation": "In a patient with MEN1 and biochemically proven endogenous hyperinsulinemic hypoglycemia (insulinoma) with negative conventional and advanced imaging, the next step is selective arterial calcium stimulation (SACS) with hepatic venous sampling. This invasive angiographic procedure can regionalize the source of insulin secretion to a specific pancreatic arterial territory (gastroduodenal, superior mesenteric, or splenic arteries), guiding targeted surgical exploration. Empiric distal or total pancreatectomy carries high morbidity and may miss the lesion. Diazoxide and somatostatin analogs are temporizing medical therapies but do not address the need for definitive localization and resection in a surgical candidate.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best answer. The vignette describes a 55-year-old man with MEN1 syndrome presenting with biochemically confirmed endogenous hyperinsulinemic hypoglycemia (elevated insulin and C-peptide during supervised fast with glucose 38 mg/dL), consistent with insulinoma. Key discriminating findings: (1) MEN1 history with prior endocrine surgeries, (2) biochemical confirmation of insulinoma, (3) negative conventional imaging (EUS) and advanced functional imaging (Ga-68 DOTATATE PET/CT). The clinical problem is localizing an occult insulinoma to guide surgical resection. Choice C (SACS with hepatic venous sampling) is the established next step when non-invasive imaging fails to localize a biochemically proven insulinoma. This invasive functional test regionalizes insulin hypersecretion to specific pancreatic arterial territories, achieving 88-94% sensitivity and guiding targeted surgical exploration. Choice A (empiric distal pancreatectomy) is inappropriate without localization—insulinomas distribute throughout the pancreas. Choice B (diazoxide) and E (somatostatin analogs) are medical temporizing measures, not definitive localization steps in a surgical candidate. Choice D (total pancreatectomy) carries excessive morbidity without attempting localization first. No logical flaws; the stem provides sufficient detail for a unique best answer. Medical accuracy is excellent—aligns with current endocrine surgery guidelines. Minimal fix: None needed; item is valid as written.\", \"medical_accuracy_score\": \"5\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The vignette describes a 55-year-old man with MEN1 syndrome presenting with biochemically confirmed endogenous hyperinsulinemic hypoglycemia (elevated insulin and C-peptide during supervised fast with glucose 38 mg/dL), consistent with insulinoma. Key discriminating findings: (1) MEN1 history with prior endocrine surgeries, (2) biochemical confirmation of insulinoma, (3) negative conventional imaging (EUS) and advanced functional imaging (Ga-68 DOTATATE PET/CT). The clinical problem is localizing an occult insulinoma to guide surgical resection. Choice C (SACS with hepatic venous sampling) is the established next step when non-invasive imaging fails to localize a biochemically proven insulinoma. This invasive functional test regionalizes insulin hypersecretion to specific pancreatic arterial territories, achieving 88-94% sensitivity and guiding targeted surgical exploration. Choice A (empiric distal pancreatectomy) is inappropriate without localization—insulinomas distribute throughout the pancreas. Choice B (diazoxide) and E (somatostatin analogs) are medical temporizing measures, not definitive localization steps in a surgical candidate. Choice D (total pancreatectomy) carries excessive morbidity without attempting localization first. No logical flaws; the stem provides sufficient detail for a unique best answer. Medical accuracy is excellent—aligns with current endocrine surgery guidelines. Minimal fix: None needed; item is valid as written.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-006", "question": "A 7-year-old boy is evaluated for short stature. He has a history of congenital hypothyroidism diagnosed on newborn screening, treated with levothyroxine. Growth chart shows length and weight at the 5th percentile at birth, falling to below the 1st percentile by age 3. Current bone age is delayed by 3 years. Physical exam reveals a prominent forehead, depressed nasal bridge, and small hands with brachydactyly. Labs show normal TSH and free T4 on replacement. Which of the following genetic mutations is most likely responsible for this clinical picture?", "options": ["SHOX gene mutation", "GH1 gene mutation (isolated GH deficiency)", "GNAS1 gene mutation (Albright hereditary osteodystrophy)", "PROP1 gene mutation (combined pituitary hormone deficiency)", "FGFR3 gene mutation (achondroplasia)"], "answer": "D", "answer_index": 3, "explanation": "The combination of congenital hypothyroidism, severe postnatal growth failure with delayed bone age, and mild facial dysmorphism is classic for combined pituitary hormone deficiency (CPHD) due to a PROP1 mutation. PROP1 is a pituitary transcription factor critical for the development of somatotrophs, lactotrophs, thyrotrophs, and gonadotrophs. Deficiency presents with growth hormone, TSH, and later gonadotropin deficiencies. The congenital hypothyroidism was central (pituitary), not primary thyroidal. SHOX mutations cause Leri-Weill dyschondrosteosis. GNAS1 mutations cause pseudohypoparathyroidism with specific skeletal findings (brachydactyly type E). Isolated GH deficiency or achondroplasia would not explain the central hypothyroidism.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: M (Multiple answers defensible). Verdict: Not uniquely determinable. The stem describes a child with congenital hypothyroidism (treated, now euthyroid), severe growth failure, delayed bone age, prominent forehead, depressed nasal bridge, small hands with brachydactyly. The key issue is that the vignette states hypothyroidism was \\\"diagnosed on newborn screening\\\" without explicitly stating it was central/secondary hypothyroidism. Newborn screening typically detects primary hypothyroidism (elevated TSH, low T4). The rationale assumes central hypothyroidism, but this is not stated in the stem. If the hypothyroidism was primary thyroidal (as newborn screening suggests), then PROP1 (D) would not explain it. The skeletal findings (brachydactyly, facial features) strongly suggest GNAS1/Albright hereditary osteodystrophy (C), which can present with growth failure and skeletal dysplasia. Both C and D are defensible depending on whether the hypothyroidism is assumed primary vs. central. The stem is underspecified regarding the type of hypothyroidism, leading to multiple defensible answers. Medical accuracy: The rationale's logic is sound IF central hypothyroidism is assumed, but the stem does not support this assumption clearly. Minimal fix: Explicitly state \\\"central hypothyroidism\\\" or provide TSH/T4 values at diagnosis indicating secondary hypothyroidism to make D uniquely defensible.\", \"medical_accuracy_score\": \"3\", \"logical_validity\": false, \"logical_false_reason\": \"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: M (Multiple answers defensible). Verdict: Not uniquely determinable. The stem describes a child with congenital hypothyroidism (treated, now euthyroid), severe growth failure, delayed bone age, prominent forehead, depressed nasal bridge, small hands with brachydactyly. The key issue is that the vignette states hypothyroidism was \"diagnosed on newborn screening\" without explicitly stating it was central/secondary hypothyroidism. Newborn screening typically detects primary hypothyroidism (elevated TSH, low T4). The rationale assumes central hypothyroidism, but this is not stated in the stem. If the hypothyroidism was primary thyroidal (as newborn screening suggests), then PROP1 (D) would not explain it. The skeletal findings (brachydactyly, facial features) strongly suggest GNAS1/Albright hereditary osteodystrophy (C), which can present with growth failure and skeletal dysplasia. Both C and D are defensible depending on whether the hypothyroidism is assumed primary vs. central. The stem is underspecified regarding the type of hypothyroidism, leading to multiple defensible answers. Medical accuracy: The rationale's logic is sound IF central hypothyroidism is assumed, but the stem does not support this assumption clearly. Minimal fix: Explicitly state \"central hypothyroidism\" or provide TSH/T4 values at diagnosis indicating secondary hypothyroidism to make D uniquely defensible.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-007", "question": "A 70-year-old man with severe, calcific aortic stenosis (AVA 0.6 cm², mean gradient 55 mmHg) and chronic kidney disease (eGFR 28 mL/min/1.73m²) presents with recurrent hospitalizations for heart failure with preserved ejection fraction (LVEF 65%). He is deemed high-risk for surgical AVR. He undergoes transcatheter aortic valve implantation (TAVI) with a balloon-expandable valve. Immediately post-deployment, transesophageal echocardiography shows a well-seated valve with mild paravalvular leak, mean gradient 8 mmHg, and new severe mitral regurgitation with a wide vena contracta and eccentric anteriorly directed jet. The left ventricular systolic function appears hyperdynamic. What is the most likely mechanism of the acute severe mitral regurgitation?", "options": ["Iatrogenic injury to the mitral valve apparatus from the delivery system", "Dynamic left ventricular outflow tract obstruction causing systolic anterior motion of the mitral valve", "Unmasking of pre-existing severe ischemic mitral regurgitation due to afterload reduction", "Valve prosthesis impingement on the anterior mitral leaflet", "Acute papillary muscle dysfunction due to coronary occlusion"], "answer": "B", "answer_index": 1, "explanation": "In a patient with severe AS and a small, hypertrophied, hyperdynamic left ventricle, relief of the afterload obstruction via TAVI can precipitate dynamic LVOT obstruction. This leads to systolic anterior motion (SAM) of the mitral valve, causing acute, severe mitral regurgitation with an eccentric anterior jet. This is a recognized complication of TAVI, particularly in patients with certain anatomical predictors (septal hypertrophy, small LV cavity). Direct injury from the delivery system is rare. Pre-existing severe MR would have been evident pre-procedure. Prosthetic impingement typically causes central MR. Coronary occlusion is possible but would more likely cause regional wall motion abnormalities and ischemic MR.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best answer. The stem describes a classic post-TAVI complication scenario with key discriminating features: (1) severe calcific AS with small valve area, (2) preserved/hyperdynamic LVEF (65%), (3) immediate post-deployment timing, (4) new severe MR with eccentric anteriorly directed jet, and (5) hyperdynamic LV systolic function. These findings strongly point to dynamic LVOT obstruction with SAM as the mechanism. Option B correctly identifies this well-recognized complication occurring when afterload reduction unmasks latent obstruction in hypertrophied, small-cavity ventricles. Option A (iatrogenic injury) is rare and wouldn't explain the hyperdynamic state or specific jet direction. Option C (unmasking ischemic MR) contradicts the preserved EF and hyperdynamic function; ischemic MR typically involves regional dysfunction. Option D (prosthetic impingement) would cause central rather than eccentric anterior MR. Option E (papillary muscle dysfunction) would show regional wall abnormalities, not hyperdynamic function. The item is medically accurate, describing a recognized TAVI complication with appropriate clinical context and echocardiographic findings. All stem clues converge on a single best answer matching the keyed response. No logical flaws or medical inaccuracies identified. Minimal fix: None needed; item is valid as written.\", \"medical_accuracy_score\": \"5\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The stem describes a classic post-TAVI complication scenario with key discriminating features: (1) severe calcific AS with small valve area, (2) preserved/hyperdynamic LVEF (65%), (3) immediate post-deployment timing, (4) new severe MR with eccentric anteriorly directed jet, and (5) hyperdynamic LV systolic function. These findings strongly point to dynamic LVOT obstruction with SAM as the mechanism. Option B correctly identifies this well-recognized complication occurring when afterload reduction unmasks latent obstruction in hypertrophied, small-cavity ventricles. Option A (iatrogenic injury) is rare and wouldn't explain the hyperdynamic state or specific jet direction. Option C (unmasking ischemic MR) contradicts the preserved EF and hyperdynamic function; ischemic MR typically involves regional dysfunction. Option D (prosthetic impingement) would cause central rather than eccentric anterior MR. Option E (papillary muscle dysfunction) would show regional wall abnormalities, not hyperdynamic function. The item is medically accurate, describing a recognized TAVI complication with appropriate clinical context and echocardiographic findings. All stem clues converge on a single best answer matching the keyed response. No logical flaws or medical inaccuracies identified. Minimal fix: None needed; item is valid as written.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-008", "question": "A 4-week-old male infant is admitted with a 2-day history of poor feeding, lethargy, and vomiting. He was born at term, breastfeeding well until this illness. Vital signs: T 36.8°C, HR 180 bpm, RR 65/min, BP 65/40 mmHg, SpO2 98% room air. He is mottled, with delayed capillary refill. Laboratory studies show: Na 125 mEq/L, K 8.9 mEq/L, Cl 94 mEq/L, CO2 14 mEq/L, glucose 48 mg/dL, Ca 9.8 mg/dL. Point-of-care cortisol is 2 mcg/dL (drawn prior to any steroid administration). Which of the following is the most urgent diagnostic test to confirm the underlying etiology?", "options": ["Plasma renin activity and aldosterone level", "Karyotype analysis", "Serum 17-hydroxyprogesterone level", "ACTH stimulation test", "Urine organic acid analysis"], "answer": "C", "answer_index": 2, "explanation": "The infant presents in acute adrenal crisis with profound hyponatremia, hyperkalemia, hypoglycemia, and low cortisol, diagnostic of primary adrenal insufficiency. The most common cause in a male infant is congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency, which is detected by a markedly elevated serum 17-hydroxyprogesterone level. This is the most urgent specific diagnostic test, as it guides definitive management and genetic counseling. Plasma renin activity will be elevated, but does not specify the etiology. Karyotype is not urgent; males with CAH have a 46,XY karyotype. An ACTH stimulation test is diagnostic for adrenal insufficiency but is contraindicated in acute crisis and does not identify the specific enzyme defect. Urine organic acids help diagnose other metabolic disorders.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V. Verdict: Correct best answer. The vignette describes a 4-week-old male with classic salt-wasting adrenal crisis: hyponatremia (125), severe hyperkalemia (8.9), hypoglycemia (48), low cortisol (2), metabolic acidosis (CO2 14), shock physiology (tachycardia, hypotension, mottling). The question asks for the most urgent diagnostic test to confirm underlying etiology. Key discriminating findings: male neonate, acute adrenal crisis presentation, low cortisol confirming primary adrenal insufficiency. Most likely diagnosis: congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency, the most common cause of primary adrenal insufficiency in neonates. Keyed answer C (serum 17-OHP) is correct: markedly elevated 17-hydroxyprogesterone is diagnostic for 21-hydroxylase deficiency CAH and can be obtained rapidly to confirm etiology. Alternative assessment: A (renin/aldosterone) confirms mineralocorticoid deficiency but doesn't specify enzyme defect; B (karyotype) not urgent, males with CAH are 46,XY; D (ACTH stim) contraindicated in acute crisis and doesn't identify specific enzyme; E (urine organic acids) for other metabolic disorders, not CAH. No logical flaws: stem provides sufficient detail, single best answer is defensible, key matches. Medical accuracy: fully consistent with standard neonatal endocrinology practice. Minimal fix: none needed; item is valid and accurate.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The vignette describes a 4-week-old male with classic salt-wasting adrenal crisis: hyponatremia (125), severe hyperkalemia (8.9), hypoglycemia (48), low cortisol (2), metabolic acidosis (CO2 14), shock physiology (tachycardia, hypotension, mottling). The question asks for the most urgent diagnostic test to confirm underlying etiology. Key discriminating findings: male neonate, acute adrenal crisis presentation, low cortisol confirming primary adrenal insufficiency. Most likely diagnosis: congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency, the most common cause of primary adrenal insufficiency in neonates. Keyed answer C (serum 17-OHP) is correct: markedly elevated 17-hydroxyprogesterone is diagnostic for 21-hydroxylase deficiency CAH and can be obtained rapidly to confirm etiology. Alternative assessment: A (renin/aldosterone) confirms mineralocorticoid deficiency but doesn't specify enzyme defect; B (karyotype) not urgent, males with CAH are 46,XY; D (ACTH stim) contraindicated in acute crisis and doesn't identify specific enzyme; E (urine organic acids) for other metabolic disorders, not CAH. No logical flaws: stem provides sufficient detail, single best answer is defensible, key matches. Medical accuracy: fully consistent with standard neonatal endocrinology practice. Minimal fix: none needed; item is valid and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-009", "question": "A 32-year-old woman with a history of systemic sclerosis (limited cutaneous variant, anti-centromere positive) presents to the rheumatology clinic for routine follow-up. She reports excellent control of her Raynaud's phenomenon and stable skin disease. She has no cardiac or renal symptoms. Her vital signs are normal. A screening transthoracic echocardiogram is performed, which reveals normal left and right ventricular size and function, but there is a small to moderate pericardial effusion. Which of the following findings on echocardiogram would be the strongest indicator to initiate specific pharmacologic therapy directed at the effusion?", "options": ["Right atrial diastolic collapse", "Respiratory variation in mitral inflow velocity >25%", "Inferior vena cava plethora with <50% collapse on sniff", "Swinging heart motion", "Left atrial compression during systole"], "answer": "C", "answer_index": 2, "explanation": "In a patient with a chronic, stable effusion (like those common in connective tissue diseases), the strongest echocardiographic sign of hemodynamic compromise (tamponade physiology) is inferior vena cava (IVC) plethora with minimal respiratory collapse (<50%). This indicates elevated right atrial pressure. In chronic effusions, the chambers have had time to adapt, so classic signs like right atrial collapse may be absent or late. Respiratory variation in mitral inflow (>25%) is a sensitive sign but can be seen in other conditions like COPD. Right atrial collapse is an early sign but less specific in chronic settings. Swinging heart is seen with very large effusions but not specific for tamponade. Left atrial compression is rare.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed - the keyed answer is not the best answer. Key stem clues: asymptomatic patient with systemic sclerosis, normal vitals, small-to-moderate pericardial effusion, no cardiac symptoms. The question asks for the \\\"strongest indicator to initiate specific pharmacologic therapy\\\" for the effusion. Right atrial diastolic collapse (A) is a specific, early echocardiographic sign of cardiac tamponade requiring intervention. The rationale's claim that IVC plethora (C) is the \\\"strongest\\\" sign is problematic: IVC findings reflect elevated RA pressure but are less specific than chamber collapse for tamponade physiology. In chronic effusions, while RA collapse may occur later, when present it remains highly specific for hemodynamic compromise warranting treatment. The rationale conflates sensitivity with clinical actionability. IVC plethora can be seen in other conditions causing elevated RA pressure (RV failure, tricuspid regurgitation, volume overload). Medical accuracy issue: The teaching point misrepresents the hierarchy of tamponade signs. Right atrial collapse is more specific for tamponade than IVC plethora, which is a supportive but less specific finding. Minimal fix: Change the key to A (right atrial diastolic collapse) or rewrite to ask for \\\"earliest\\\" rather than \\\"strongest\\\" indicator, clarifying that IVC findings support but don't define tamponade.\", \"medical_accuracy_score\": \"3\", \"logical_validity\": false, \"logical_false_reason\": \"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed - the keyed answer is not the best answer. Key stem clues: asymptomatic patient with systemic sclerosis, normal vitals, small-to-moderate pericardial effusion, no cardiac symptoms. The question asks for the \"strongest indicator to initiate specific pharmacologic therapy\" for the effusion. Right atrial diastolic collapse (A) is a specific, early echocardiographic sign of cardiac tamponade requiring intervention. The rationale's claim that IVC plethora (C) is the \"strongest\" sign is problematic: IVC findings reflect elevated RA pressure but are less specific than chamber collapse for tamponade physiology. In chronic effusions, while RA collapse may occur later, when present it remains highly specific for hemodynamic compromise warranting treatment. The rationale conflates sensitivity with clinical actionability. IVC plethora can be seen in other conditions causing elevated RA pressure (RV failure, tricuspid regurgitation, volume overload). Medical accuracy issue: The teaching point misrepresents the hierarchy of tamponade signs. Right atrial collapse is more specific for tamponade than IVC plethora, which is a supportive but less specific finding. Minimal fix: Change the key to A (right atrial diastolic collapse) or rewrite to ask for \"earliest\" rather than \"strongest\" indicator, clarifying that IVC findings support but don't define tamponade.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-010", "question": "A 16-year-old girl is brought to the ED after collapsing during her high school soccer game. She was pulseless and apneic but received immediate bystander CPR and was defibrillated once with ROSC after 4 minutes. Her initial ECG in the ED shows sinus rhythm with diffuse ST-segment elevation in precordial leads V1-V4 and inferior leads II, III, aVF. Bedside echocardiogram shows severe hypokinesis of the mid to apical left ventricle with hypercontractility of the basal segments. Troponin I is elevated at 15 ng/mL. Which of the following is the most critical next step in management to prevent recurrence?", "options": ["Immediate coronary angiography", "Initiation of an intravenous beta-blocker", "Insertion of a wearable cardioverter-defibrillator", "Initiation of intravenous immunoglobulin (IVIG)", "Administration of intravenous calcium gluconate"], "answer": "B", "answer_index": 1, "explanation": "The clinical presentation and echocardiographic findings are classic for Takotsubo (stress) cardiomyopathy, which can rarely present with ventricular fibrillation arrest. The ECG can mimic STEMI. The most critical step to prevent recurrence of malignant arrhythmias in the acute phase is suppression of catecholamine-driven triggered activity with an intravenous beta-blocker. Immediate coronary angiography is often performed to rule out acute coronary syndrome, but the typical regional wall motion abnormality (apical ballooning) and clinical context make it less likely to be the immediate preventive measure for recurrence. ICD implantation is not indicated in the acute phase of a reversible cardiomyopathy. IVIG is for myocarditis. Calcium is for hyperkalemia or calcium channel blocker overdose.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: M (Multiple answers defensible). Verdict: Not uniquely determinable. The stem describes a 16-year-old with cardiac arrest, ROSC, diffuse ST-elevation, and apical ballooning pattern consistent with Takotsubo cardiomyopathy. Key discriminating findings: young athlete, sudden arrest with VF, apical hypokinesis with basal hypercontractility, elevated troponin. The question asks for the \\\"most critical next step to prevent recurrence.\\\" Both B (IV beta-blocker) and A (coronary angiography) are defensible. While beta-blockers address catecholamine-driven arrhythmias in Takotsubo, immediate coronary angiography is standard-of-care in young patients with cardiac arrest and ST-elevation to exclude coronary anomalies, spontaneous coronary artery dissection (SCAD), or atherosclerotic disease—all critical reversible causes in this demographic. The rationale dismisses angiography as \\\"less likely to be the immediate preventive measure,\\\" but ruling out anatomic coronary pathology is essential before attributing arrest solely to Takotsubo. The stem lacks explicit exclusion of coronary causes (e.g., prior normal coronary imaging), making both options defensible as \\\"most critical.\\\" Medical accuracy: The teaching point about beta-blockers in Takotsubo is reasonable but oversimplifies acute management priorities. Minimal fix: Add \\\"coronary angiography shows normal coronaries\\\" to the stem to uniquely support beta-blocker as the preventive step.\", \"medical_accuracy_score\": \"3\", \"logical_validity\": false, \"logical_false_reason\": \"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: M (Multiple answers defensible). Verdict: Not uniquely determinable. The stem describes a 16-year-old with cardiac arrest, ROSC, diffuse ST-elevation, and apical ballooning pattern consistent with Takotsubo cardiomyopathy. Key discriminating findings: young athlete, sudden arrest with VF, apical hypokinesis with basal hypercontractility, elevated troponin. The question asks for the \"most critical next step to prevent recurrence.\" Both B (IV beta-blocker) and A (coronary angiography) are defensible. While beta-blockers address catecholamine-driven arrhythmias in Takotsubo, immediate coronary angiography is standard-of-care in young patients with cardiac arrest and ST-elevation to exclude coronary anomalies, spontaneous coronary artery dissection (SCAD), or atherosclerotic disease—all critical reversible causes in this demographic. The rationale dismisses angiography as \"less likely to be the immediate preventive measure,\" but ruling out anatomic coronary pathology is essential before attributing arrest solely to Takotsubo. The stem lacks explicit exclusion of coronary causes (e.g., prior normal coronary imaging), making both options defensible as \"most critical.\" Medical accuracy: The teaching point about beta-blockers in Takotsubo is reasonable but oversimplifies acute management priorities. Minimal fix: Add \"coronary angiography shows normal coronaries\" to the stem to uniquely support beta-blocker as the preventive step.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 3}]